Company Overview
CNA Financial Corporation (NYSE: CNA) is one of the largest U.S. commercial property and casualty (P&C) insurance companies, with a history spanning over 120 years ([1]). CNA offers a broad range of standard and specialized P&C insurance products for businesses and professionals across the U.S., Canada, and Europe ([1]). A majority-owned subsidiary of conglomerate Loews Corporation, CNA’s shareholder structure is dominated by Loews, which owned approximately 92% of CNA’s outstanding common stock as of year-end 2024 ([2]). This controlling stake means Loews can largely dictate corporate actions that require stockholder approval (e.g., electing directors or approving mergers) ([2]), leaving a small public float and limited influence for minority investors.
Despite its P&C focus, CNA also maintains a Life & Group segment – perhaps the “unexpected pregnancy” in its portfolio. This segment houses long-duration policies like long-term care insurance and structured settlement annuities ([2]). Managing these long-tail liabilities can be challenging, as the required reserve assumptions (e.g., morbidity and policyholder persistency for long-term care) span decades and are subject to significant estimation risk ([2]). The Life & Group unit has occasionally weighed on results; for example, in Q4 2024 it posted a small core loss of $18 million (vs. a slight profit a year earlier) ([3]). CNA segregates certain invested assets specifically to support its long-term care and structured settlement liabilities ([2]), reflecting a cautious approach to this non-core book. Overall, while CNA’s core strength lies in P&C underwriting – evidenced by a solid 93.1% combined ratio in Q4 2024 ([3]) – the presence of the Life & Group segment introduces a unique wrinkle (a “pro-life” business line born somewhat unexpectedly) to an otherwise P&C-centric insurer.
Dividend Policy & History
CNA has a shareholder-friendly dividend policy, characterized by steady regular dividends augmented by sizable special payouts. The company has consistently raised its regular quarterly dividend by about 5% annually in recent years. For instance, CNA increased its quarterly dividend to $0.44 per share for 2024 (up from $0.42 in 2023) ([4]), and more recently to $0.46 per share for 2025 ([3]). These regular dividends alone amount to roughly $1.76–$1.84 per share on an annualized basis. On top of that, CNA has declared special dividends at year-end with increasing frequency and magnitude. Following strong results, the Board rewarded shareholders with a $2.00 per share special dividend in early 2024 (relating to 2023 results) ([4]), and repeated a $2.00 special in early 2025 (for 2024 results) ([3]). A year prior, the special dividend was $1.20 per share (after 2022) when the regular payout was lower, indicating an upward trend in these one-off distributions ([5]).
Will you be first in line for the biggest dividend in U.S. history?
Discover the secret royalty checks Americans are already collecting — and how to start getting yours next month.
Thanks to these hefty specials, CNA’s dividend yield is substantial. Including the latest special, the trailing 12-month dividend was about $3.84 per share ([6]). At the current share price in the mid-$40s, this equates to a yield in the ballpark of 8.3% ([7]) – far above the average for insurance peers. Even excluding the non-recurring specials, the base quarterly dividends ($1.84 annualized) provide a solid 4% yield. The company’s ability to sustain such payouts is underpinned by its earnings and capital generation: in 2024, CNA paid out $1,025 million in dividends to shareholders ([2]), which was about 78% of its core income for the year (core earnings exclude volatile investment gains/losses). Notably, Loews Corporation, as a 92% owner, is the prime beneficiary of these dividends – a dynamic that likely encourages CNA’s generous distribution policy. While the special dividends are not guaranteed going forward, CNA’s recent pattern of returning excess capital suggests that shareholders (and Loews) can reasonably hope for continued supplemental payouts barring any major capital needs or downturns.
Leverage and Debt Maturities
CNA’s balance sheet leverage appears moderate for an insurer, and the company has been proactive in managing its debt maturities. As of December 31, 2024, CNA had about $3.0 billion in outstanding senior notes ([2]). This debt load is relatively modest, equating to roughly 20% of total capital (debt plus equity) – a comfortable level for a stable insurance operation. The debt is laddered across multiple maturities, each roughly $500 million in face value, which helps mitigate refinancing risk. After repaying a $550 million note that came due in May 2024 ([2]), CNA’s next significant maturities are $500 million due in March 2026 (4.50% coupon) and another $500 million due in August 2027 (3.45% coupon) ([2]). Beyond that, CNA has notes maturing in 2029, 2030, 2033, and 2034 – generally spaced out in a manageable schedule ([2]). This staggered maturity profile (roughly $500 million coming due every 1–3 years after 2026) reduces the risk of a large lump-sum refinancing at any single point in time.
Importantly, CNA has already demonstrated prudence in its capital management by pre-financing future needs at opportunistic times. For example, in 2023 the company issued $500 million of 5.50% senior notes due 2033 to bolster liquidity ([2]), and concurrently redeemed a higher-coupon 7.25% debenture that was maturing in late 2023 ([2]). Again in 2024, CNA accessed the debt market and raised a $500 million 5.125% note due 2034 (evidenced by its appearance on the year-end debt schedule) ([2]). These moves refinanced near-term obligations with longer-dated debt at reasonable interest rates, pushing out the maturity wall. CNA also maintains a $250 million revolving credit facility which was undrawn at last report ([2]), providing additional liquidity for general corporate purposes or unexpected needs. Overall, CNA’s leverage is well contained – interest expense was about $133 million in 2024 ([2]), easily covered by operating earnings – and the company’s investment-grade credit ratings carry a positive outlook from A.M. Best and Moody’s as of late 2024 ([2]). This positive outlook reflects improved financial strength and gives CNA flexibility to refinance or raise debt on favorable terms if needed.
Financial Coverage and Performance
From an operating performance standpoint, CNA’s recent results highlight solid underwriting profitability and robust investment income, which together provide strong coverage for its obligations. The property & casualty (P&C) combined ratio – a key measure of underwriting health – was 93.1% in Q4 2024 (and 91.4% on an underlying basis excluding catastrophes) ([3]). A ratio under 100% means the insurance operations are writing business at an underwriting profit (premiums exceed claims and expenses), leaving investment income as pure upside. CNA’s combined ratio has consistently hovered in the low-90s in recent periods ([3]) ([4]), on par with many peers and indicative of disciplined risk selection and pricing. Net written premiums in core P&C segments grew about 10% year-over-year in Q4 2024 ([3]), and renewal pricing saw positive increases (+3% rate within a +4% overall renewal premium rise) ([3]), suggesting a still-favorable market environment for commercial insurance.
On the investment side, net investment income has been a growing contributor to earnings, thanks in part to higher interest rates. CNA’s portfolio – over $47 billion of invested assets as of 2024 ([1]), largely in fixed income – benefited from yields trending up. In Q4 2024, net investment income was $644 million pre-tax, up 5% year-over-year ([3]), building on a 21% jump seen in Q4 2023 ([4]). Rising yields on the bond portfolio and solid returns from limited partnership investments supported this growth ([3]) ([4]). This investment income, combined with underwriting profits, resulted in record core earnings for CNA in both 2023 and 2024. Full-year 2024 core income was about $4.83 per share (a company record) ([3]), which translates to roughly $1.3 billion – comfortably above the $1.0 billion of dividends paid out. Even GAAP net income (which includes unrealized investment gains/losses and unusual items) was $959 million for 2024 ([3]), covering the regular dividend outlay. Interest coverage is strong: with only ~$133 million in interest expense ([2]), CNA’s earnings before interest and taxes (EBIT) is many times that figure. In short, coverage of fixed charges and dividends by internally generated funds appears ample, absent any unforeseen hit to profitability.
It’s also worth noting that CNA’s insurance reserves remain a point of scrutiny, especially for long-tail lines. The company conducts annual reserve reviews for its long-term care and other run-off liabilities, making adjustments as needed. In recent years, reserve assumptions have been tweaked (e.g. modest strengthening of long-term care reserves by $15 million in 2023) ([2]), but there have been no alarming reserve gaps disclosed. CNA’s consistent underwriting margins and reserve discipline help ensure that earnings are real and not merely the result of drawing down prior reserves.
Valuation Profile
In the equity market, CNA’s stock is somewhat under-the-radar (given its small public float), but by standard metrics it appears reasonably valued if not slightly cheap relative to peers. The shares trade around $46 as of mid-January 2026 ([6]). Based on trailing earnings per share of ~$3.66 (GAAP) ([6]), the stock carries a P/E ratio of roughly 12.7× – in line with or a tad below the broader market, despite CNA’s high-quality P&C franchise. Forward-looking, analysts expect earnings to improve (consensus may be factoring in fewer one-time charges like 2024’s pension settlement), bringing the forward P/E down to around 9–10× ([6]). On a book value basis, CNA also looks modestly priced. The book value per share (BVPS) was $38.82 at 2024’s end (or $46.16 excluding accumulated other comprehensive income, which adjusts for unrealized investment losses) ([3]). The stock is thus trading at roughly 1.0× book (ex-AOCI) – basically at the adjusted book value of its net assets. Many P&C peers with comparable profitability trade at higher multiples of book value, though CNA’s inclusion of a life & long-term care segment (with its associated risks and higher capital needs) may be a valuation drag.
One area where CNA’s valuation stands out is the dividend yield, as discussed. At ~8% including specials ([7]), CNA’s yield is multiple times higher than most insurance peers (which typically yield 2–3%). This could imply the market is somewhat skeptical that the generous special dividends will persist indefinitely, or it simply reflects the company’s unique payout strategy under Loews’ ownership. If one considers only the regular dividend (currently about 4% yield), the remaining ~4% is a kind of “Loews bonus” that could be turned off if conditions deteriorate. Nonetheless, for income-oriented investors, CNA offers a compelling cash return profile at the current valuation. The price-to-book ~1× and mid-teens return on equity (core ROE was elevated due to strong results) together suggest the stock is not overvalued. In fact, any improvement in the underpriced Life & Group book or continued stable underwriting could make CNA an attractive value play in the insurance sector. The main caveat is the low trading liquidity and control by Loews, which means the stock might not quickly correct any undervaluation through typical market mechanics (since Loews is unlikely to sell its stake, and there’s limited arbitrage or takeover possibility).
Risks and Red Flags
While CNA is fundamentally solid, investors should be mindful of several risks and potential red flags:
– Catastrophe Exposure & Underwriting Cycle: As a P&C insurer, CNA is exposed to losses from natural catastrophes (hurricanes, wildfires, etc.) and to the cyclical pricing of insurance markets. A bad catastrophe season or a turn in the underwriting cycle (e.g. excess competition driving down premium rates) could spike the combined ratio above 100%, eroding profitability. In recent quarters CNA’s cat losses have been modest (e.g. only ~1–2 points on the combined ratio) ([3]), but this can change unpredictably. A few large losses or an industry downturn could pressure earnings and, by extension, the company’s ability to keep paying large dividends.
– Reserve Adequacy (Long-Tail Liabilities): CNA carries long-tail liabilities, especially in its Life & Group segment, such as long-term care (LTC) insurance policies and legacy mass tort claims (asbestos/environmental). Estimating reserves for these can be difficult – small assumption changes in lapse rates, morbidity, or longevity can materially impact required reserves ([2]). The LTC business in particular has a history across the industry of under-reserving. While CNA conducts regular reserve reviews and has made only minor adjustments recently ([2]), there’s a risk that adverse development (e.g. higher-than-expected claims in old accident years) could necessitate a significant reserve charge. Any large reserve strengthening would hit earnings and potentially capital, posing a risk to dividend capacity.
– Investment Portfolio & Interest Rates: CNA’s $47+ billion investment portfolio ([1]) is mostly fixed-income securities. Rapid interest rate movements can impact the portfolio’s market value and income. Rising rates have helped investment income in the short run, but they also mean CNA is carrying unrealized losses on bonds purchased when yields were lower (reflected in the ($7.34) per-share hit to AOCI at end of 2024) ([3]). If CNA needed to sell assets to pay large claims or meet other obligations, those losses could be realized. Additionally, credit risk in the portfolio is a consideration – a severe economic downturn could trigger bond defaults or downgrades affecting CNA’s investments. So far, the portfolio is high-quality and well-managed, but this is a space to watch.
– Concentrated Ownership & Governance: Loews Corporation’s 92% ownership introduces corporate governance considerations. Minority shareholders have virtually no say in corporate matters, and conflicts of interest could arise (several CNA board members are Loews executives) ([2]). For example, Loews might prefer CNA to upstream excess capital (via dividends) to fund Loews’s other endeavors, which could potentially limit CNA’s growth reinvestment. Additionally, the tiny public float means low liquidity – it may be hard for investors to build or exit positions without moving the stock price. This ownership structure is a double-edged sword: while Loews provides stability and likely long-term support, it can also act contrary to minority shareholder interests (there is always a remote risk Loews could take CNA private at a time or price not ideal for others, or conversely, keep it public but without pursuing initiatives that could unlock value for the minority).
– Life & Group Segment Drag: The non-core life/annuity business, including LTC, could continue to be a drag on results or consume capital. In Q4 2024 this segment incurred a small loss ([3]), and the nature of long-duration contracts is that surprises (positive or negative) tend to play out over many years. A red flag would be any indications of deteriorating experience in the LTC block – e.g. higher claims or regulatory changes – which might force CNA to bolster reserves. Additionally, new accounting standards for long-duration insurance contracts (e.g. GAAP LDTI) increase transparency and could introduce volatility in how these reserves are reported.
– Other Operational Risks: Like any insurer, CNA faces operational and emerging risks. Litigation trends (e.g. social inflation in liability claims), regulatory changes, or cybersecurity incidents (CNA itself was hit by a ransomware attack in 2021) can all pose financial and reputational risks. While not unique to CNA, these factors are worth monitoring.
Overall, CNA’s risk profile is quite typical for a large insurer – with the added nuance of its legacy LTC exposure. The company’s recent performance and capital actions suggest it is managing these risks prudently, but investors should remain vigilant for any changes in reserve trends or underwriting discipline that could signal trouble.
Valuation and Open Questions
Despite its stable business and high payout, CNA’s stock has not commanded a premium valuation – likely due in part to its ownership structure and the “show-me” nature of some of its earnings (e.g. reliance on investment income and reserve releases). This raises a few open questions for investors going forward:
– Will the outsized special dividends continue? CNA’s dividend strategy of annual specials has been very shareholder-friendly. The sustainability of these $2.00/share extra payouts is a key question. Are they a result of temporary capital surpluses (from strong investment gains or reserve redundancies), or has CNA adopted a long-term practice of returning excess capital given its conservative underwriting? Management’s guidance on capital return policy will be worth watching in upcoming earnings calls. A related point: even after paying $3.76 in dividends per share in 2024, CNA’s book value (ex-AOCI) still grew 8% ([3]), which suggests capacity for continued payouts – but conditions can change.
– What is the future of the Life & Group segment? This segment is small relative to CNA’s P&C operations but carries disproportionate risk. Investors might wonder if CNA (and Loews) plan to run off, divest, or otherwise de-risk the long-term care and annuity liabilities. Some peers have exited such businesses via reinsurance or sales. Any move to shed this segment could improve CNA’s valuation by making it a pure-play P&C insurer. Conversely, retaining it means ongoing questions about reserve adequacy and capital allocation to support long-duration policies. Clarity on management’s strategy here would help reduce the “conglomerate discount” on CNA’s stock.
– How will CNA deploy its capital going forward? Beyond dividends, CNA has done only modest share buybacks (e.g. $20 million in 2024, which is negligible given a $12+ billion market cap) ([2]). With Loews in control, widespread buybacks are unlikely (since reducing the float further has little appeal). So, the question is: if earnings continue to outpace regular dividends, will CNA keep accumulating excess capital, or keep paying it out via specials? Also, if attractive opportunities arise (either acquisitions in commercial insurance or organic growth), is CNA inclined to reinvest more of its profits rather than distribute them? The balance between growth and shareholder yield is an open question.
– Could Loews alter its approach to CNA? Loews has held CNA for decades as a core holding. The current arrangement provides Loews with a steady stream of cash (CNA’s dividends contributed significantly to Loews’s own cash flow). An open question is whether Loews might ever seek to buy the remaining public stake (to fully privatize CNA) or, conversely, spin off some of its CNA shares to unlock value. There’s no indication of such moves imminently, but strategic shifts at the parent level could impact CNA shareholders. Minority investors must essentially trust Loews’ stewardship, highlighting the importance of any signals from Loews management regarding CNA’s role in the conglomerate.
– How will rising interest rates and economic conditions affect CNA’s performance? Thus far, higher interest rates have been a net positive for CNA’s investment returns ([4]). However, if rates continue to climb or remain volatile, there could be second-order effects: higher discount rates could reduce the present value of insurance liabilities (an accounting positive) but also potentially soften insurance pricing if investment income alone can bolster profits (leading to competitive premium cuts). Additionally, inflation and economic slowdowns can influence CNA’s loss costs and premium growth. The open question is whether CNA can continue its favorable trajectory of core income growth in a changing macro environment, or if headwinds (inflation in claims, recession impacting insured businesses) will emerge.
In conclusion, CNA Financial presents a unique mix of steady insurance operations, a high dividend payout, and an unusual ownership structure. The company’s “unexpected” life & group business adds complexity but is being managed conservatively. For investors, the stock offers an attractive yield and decent value, albeit with lower liquidity and a reliance on the majority owner’s decisions. Going forward, clarity on capital strategy and continued disciplined underwriting will be key. CNA’s story is one of a venerable insurer balancing tradition (P&C coverage for over a century) with adaptation (navigating modern risks and legacy liabilities) – truly a case of an old-line company still finding new ways to deliver for stakeholders, including that pro-life segment born from its own corporate history. The next chapters will reveal how CNA nurtures this mix and whether the market comes to fully appreciate it.
Sources: CNA Financial 2024 Earnings Release ([3]) ([3]); CNA Financial 2023 Earnings Release ([4]) ([4]); SEC Form 10-K (2024) ([2]) ([2]); Loews Corp. Company Overview ([1]); StockAnalysis Profile ([6]); Fintel Dividend Data ([7]).
Sources
- https://loews.com/subsidiaries/cna-financial/default.aspx
- https://content.edgar-online.com/ExternalLink/EDGAR/0000021175-25-000008.html?dest=cna-20241231_htm&%3Bhash=b7159e498c33f792146461e9dd25b58316b9869fe1f41b44a6f0d0fd20fc6359
- https://investor-relations.cna.com/news/news-details/2025/CNA-FINANCIAL-ANNOUNCES-Q4-2024-NET-INCOME-OF-0.07-PER-SHARE-AND-CORE-INCOME-OF-1.25-PER-SHARE-FULL-YEAR-2024-NET-INCOME-OF-3.52-PER-SHARE-AND-RECORD-CORE-INCOME-OF-4.83-PER-SHARE-REGULAR-QUARTERLY-DIVIDEND-INCREASED-5-TO-0.46-PER-SHARE-SPECIAL-DIVID/default.aspx
- https://stocktitan.net/news/CNA/cna-financial-announces-q4-2023-net-income-of-1-35-per-share-and-qh2q0m0clzzc.html
- https://seekingalpha.com/news/3932196-cna-financial-raises-dividend-by-5-to-042-dividend-announces-special-dividend-of-120
- https://stockanalysis.com/stocks/cna/
- https://fintel.io/sd/us/cna
For informational purposes only; not investment advice.
